Skip to main content

Want a detailed portfolio tracker?

Cara Therapeutics (TVRD) Revenue (2013 - 2026)

Cara Therapeutics (TVRD) revenue from Mar 31, 2013 to Mar 31, 2026. The TTM Cara Therapeutics (TVRD) revenue is -$940K. You can adjust inflation or export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

Annual Revenue

Quarterly Revenue

Annual Revenue change of Cara Therapeutics (TVRD)

YearRevenueChange
2026$250K-81.88%
2025$1.38M-80.67%
2024$7.14M-65.95%
2023$21M-49.92%
2022$42M+81.81%
2021$23M-82.95%
2020$135M+579.14%
2019$20M+47.66%
2018$13M+1380.22%
2017$910K+911.11%
2016$90K-97.63%
2015$3.80M+19.50%
2014$3.18M-73.41%
2013$12M+905.04%
2012$1.19MN/A